相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modulators of CXCR4 and CXCR7/ACKR3 Function
Ilze Adlere et al.
MOLECULAR PHARMACOLOGY (2019)
CXCR4 involvement in neurodegenerative diseases
Luke W. Bonham et al.
TRANSLATIONAL PSYCHIATRY (2018)
CXCR4-directed theranostics in oncology and inflammation
Malte Kircher et al.
ANNALS OF NUCLEAR MEDICINE (2018)
Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum
Roland Boettger et al.
PLOS ONE (2017)
Novel Peptides Derived from Dengue Virus Capsid Protein Translocate Reversibly the Blood-Brain Barrier through a Receptor-Free Mechanism
Vera Neves et al.
ACS CHEMICAL BIOLOGY (2017)
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
M. Katie Conley-LaComb et al.
MOLECULAR CANCER (2016)
Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists
Rama K. Mishra et al.
SCIENTIFIC REPORTS (2016)
Immunophenotyping of rheumatoid arthritis reveals a linkage between HLA-DRB1 genotype, CXCR4 expression on memory CD4+ T cells, and disease activity
Yasuo Nagafuchi et al.
SCIENTIFIC REPORTS (2016)
Mining viral proteins for antimicrobial and cell-penetrating drug delivery peptides
Joao Miguel Freire et al.
BIOINFORMATICS (2015)
CXCR4 in breast cancer: oncogenic role and therapeutic targeting
Chao Xu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Discovery and Characterization of an Endogenous CXCR4 Antagonist
Onofrio Zirafi et al.
CELL REPORTS (2015)
Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action
Joao M. Freire et al.
FEBS JOURNAL (2014)
Antiretroviral Treatment of Adult HIV Infection 2014 Recommendations of the International Antiviral Society-USA Panel
Huldrych F. Guenthard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Future directions for peptide therapeutics development
Allan A. Kaspar et al.
DRUG DISCOVERY TODAY (2013)
HIPdb: A Database of Experimentally Validated HIV Inhibiting Peptides
Abid Qureshi et al.
PLOS ONE (2013)
Intracellular Nucleic Acid Delivery by the Supercharged Dengue Virus Capsid Protein
Joao Miguel Freire et al.
PLOS ONE (2013)
Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine
Odile Launay et al.
VACCINE (2013)
Small Molecule Inhibitors of CXCR4
Bikash Debnath et al.
THERANOSTICS (2013)
HIV-1 entry inhibitors: recent development and clinical use
Timothy J. Henrich et al.
CURRENT OPINION IN VIROLOGY (2013)
Baseline susceptibility of primary HIV-2 to entry inhibitors
Pedro Borrego et al.
ANTIVIRAL THERAPY (2012)
A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4+ T-Cell Recovery Despite Sustained Virologic Suppression: ACTG A5256
Timothy J. Wilkin et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Pathogenic Mechanisms of HIV Disease
Susan Moir et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Multifaceted action of Fuzeon as virus-cell membrane fusion inhibitor
Avraham Ashkenazi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases
Won-Tak Choi et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Phage Display of Combinatorial Peptide Libraries: Application to Antiviral Research
Guillaume Castel et al.
MOLECULES (2011)
A time-of-drug addition approach to target identification of antiviral compounds
Dirk Daelemans et al.
NATURE PROTOCOLS (2011)
ADS-J1 Inhibits HIV-1 Entry by Interacting with gp120 and Does Not Block Fusion-Active gp41 Core Formation
Emmanuel Gonzalez-Ortega et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Synthetic therapeutic peptides: science and market
Patrick Vlieghe et al.
DRUG DISCOVERY TODAY (2010)
Design of a Potent D-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance
Brett D. Welch et al.
JOURNAL OF VIROLOGY (2010)
Novel HIV-1 Knockdown Targets Identified by an Enriched Kinases/Phosphatases shRNA Library Using a Long-Term Iterative Screen in Jurkat T-Cells
Sylvie Rato et al.
PLOS ONE (2010)
Immune and Inflammatory Mechanisms of Atherosclerosis
Elena Galkina et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
CXCR4 mediates the proliferation of glioblastoma progenitor cells
Moneeb Ehtesham et al.
CANCER LETTERS (2009)
Peptides in the treatment of AIDS
Fred Naider et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2009)
A New Generation of Peptide-based Inhibitors Targeting HIV-1 Reverse Transcriptase Conformational Flexibility
Audrey Agopian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Potential limitation of CCR5 antagonists: drug resistance more often linked to CXCR4-utilizing than to CCR5-utilizing HIV-1
Thor A. Wagner et al.
AIDS (2008)
AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice
Anna C. Pulliam et al.
EXPERIMENTAL HEMATOLOGY (2008)
Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr)
Iris Oz Gleenberg et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro
Coralie Martin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: Insight into the binding mode of the enzyme
Hui-Yuan Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4
C. C. Schimanski et al.
BRITISH JOURNAL OF CANCER (2006)
HIV-1 coreceptor use in triple-class treatment experienced patients: Baseline prevalence, correlates, and relationship to enfuvirtide response
Tom Melby et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity
P Dorr et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity
K Skrabal et al.
JOURNAL OF VIROLOGY (2005)
Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase
IO Gleenberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival
J Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Anti-CXCR4 monoclonal antibodies recognizing overlapping epitopes differ significantly in their ability to inhibit entry of human immunodeficiency virus type 1
X Carnec et al.
JOURNAL OF VIROLOGY (2005)
Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry
J Daecke et al.
JOURNAL OF VIROLOGY (2005)
Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20)
J Lu et al.
JOURNAL OF VIROLOGY (2004)
Enfuvirtide: The first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes
T Matthews et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission
L Wu et al.
VIROLOGY (2004)
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection
CW Hendrix et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
CXCR4-Tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes
K Balabanian et al.
JOURNAL OF IMMUNOLOGY (2004)
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
M Darash-Yahana et al.
FASEB JOURNAL (2004)
Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells
M Burger et al.
ONCOGENE (2003)
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America
JP Lalezari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia
A Lazzarin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type I isolates
A Amara et al.
JOURNAL OF VIROLOGY (2003)
CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells
JH Hwang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Evaluation of SDF-1/CXCR4-induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry
K Princen et al.
CYTOMETRY PART A (2003)
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes
M Cavrois et al.
NATURE BIOTECHNOLOGY (2002)
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
S Hatse et al.
FEBS LETTERS (2002)
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates
H Golding et al.
JOURNAL OF VIROLOGY (2002)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Biodistribution and catabolism of F-18-labeted neurotensin(8-13) analogs
R Bergmann et al.
NUCLEAR MEDICINE AND BIOLOGY (2002)
A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma
H Geminder et al.
JOURNAL OF IMMUNOLOGY (2001)
Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1
BS Jin et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2000)
The plasma membrane as a combat zone in the HIV battlefield
RW Doms et al.
GENES & DEVELOPMENT (2000)
Chemical and physiological characterization of fluo-4 Ca2+-indicator dyes
KR Gee et al.
CELL CALCIUM (2000)
分享论文
